樂觀
$14.32
情境價格
$29.290
-0.258 (-0.88%)收盤時
Pediatrix Medical Group, Inc. is a provider of physician services, including newborn, maternal-fetal, and other pediatric subspecialty care. The Company’s affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by pediatric subspecialties. It offers specialized and critical care services through approximately 4,400 affiliated physicians and other clinicians. It provides neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. The Company provides maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.
Pediatrix Medical Group Inc is currently a hold. The stock is trading at $29.29, which is above the recent analyst target of $28 from Jefferies. The RSI is at 78.905, indicating that the stock is overbought, which may lead to a price correction. Despite a strong year-to-date change of +37.58% and a forward P/E of 9.2937, the recent downgrade and potential earnings growth cap present risks.
Jefferies
$28
2026-08-19
Jefferies
2026-08-19
目標價
$28
UBS
$28
2026-08-06
UBS
2026-08-06
目標價
$28
Deutsche Bank
$25
2026-08-05
Deutsche Bank
2026-08-05
目標價
$25
UBS
$25
2026-05-12
UBS
2026-05-12
目標價
$25
Mizuho
$24
2026-05-08
Mizuho
2026-05-08
目標價
$24
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

Pediatrix Medical Group Q2 Earnings Highlights

Surge in Options Trading Volume for Celanese and Pediatrix

Pediatrix Medical Group Q2 2026 Earnings Call Insights

Pediatrix Medical Group Reports Q2 2026 Earnings

Pediatrix Medical Group Q2 Earnings Exceed Expectations
Pediatrix Medical Group, Inc. is a provider of physician services, including newborn, maternal-fetal, and other pediatric subspecialty care. The Company’s affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by pediatric subspecialties. It offers specialized and critical care services through approximately 4,400 affiliated physicians and other clinicians. It provides neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. The Company provides maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice. It operates in the Healthcare sector (SERVICES-HOSPITALS industry).
Pediatrix Medical Group Inc is currently a hold. The stock is trading at $29.29, which is above the recent analyst target of $28 from Jefferies. The RSI is at 78.905, indicating that the stock is overbought, which may lead to a price correction. Despite a strong year-to-date change of +37.58% and a forward P/E of 9.2937, the recent downgrade and potential earnings growth cap present risks.
14 analysts cover MD: 3 rate it Buy, 10 Hold and 1 Sell. The average price target is 23.50.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。